NCT00572052

Comparison of Glycemic Control Achieved With 2 Different Needles

Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 62 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

This trial is conducted in the United States of America (USA). The aim of this trial is to investigate if a 31 gauge x 6 mm needle will provide comparable blood glucose control to the 29 gauge x 12.7 mm needle in obese subjects with diabetes.

Conditions

• Diabetes
• Diabetes Mellitus, Type 1
• Diabetes Mellitus, Type 2
• Delivery Systems

Interventions

Type	Name	Description
DEVICE	NovoFine® needle 6 mm
DEVICE	Ultra-Fine needle 12.7 mm

Timeline

• Start date: 2002-12-01
• Primary completion: 2003-10-01
• Completion: 2003-10-01
• First posted: 2007-12-12
• Last updated: 2017-01-19

Locations

5 sites across 1 country: United States